![]()
Dear Jessica,
Last year, the Pacific South Coast Chapter launched the Golden Circle Giving Club asking donors to join with a gift of $1,000 or more. In its inaugural year, 116 donors answered the call for assistance, raising hundreds of thousands of dollars to support people living with multiple sclerosis.
Did you know that this level of support underwrites the chapter’s entire financial assistance program, which helped over 500 people last year? The chapter provides a wide array of programs and services for individuals with MS and their families to enhance their lives and create avenues toward greater independence.
Our chapter can help individuals with obtaining services in financial assistance, transportation, equipment and more. Please consider a donation to Golden Circle, which may be restricted to directly support these important financial programs.
Best regards,
Karen Barton
Vice President, Leadership Giving & Events
![]()

Check out the latest edition of the MSConnection! In this quarter's issue we have information about:
-
November is National Family
Caregivers Month - Recaps from fundraising events, Challenge Walk MS & Bike MS
- CHAD Volunteer of the Year Award
-
Upcoming support groups
and teleconferences - Angel Visitation Program celebrates its 10th year
-
And much more!
![]()
Enjoy an Italian evening at the MS Dinner Auction! Join us for the 18th Annual MS Dinner Auction sponsored by Azamara Club Cruises at the Loews Coronado Bay Resort on November 20. Enjoy complimentary champagne, exciting silent and live auction packages, live entertainment and a gourmet dinner. Register or find out more.
![]()
Join us for the Annual Sycuan Holiday Family Party on Sunday, December 19. Guests will be treated to a delicious brunch buffet and enjoy fabulous entertainment and activities. Santa and his elves will also make a special appearance bearing gifts for all the good little boys and girls. Reserve your spot today!
![]()
The U.S. Food and Drug Administration has approved fingolimod capsules (Gilenya,™ Novartis International AG) for reducing the frequency of clinical relapses and delaying the accumulation of physical disability in relapsing forms of MS, making it the first oral disease-modifying therapy for the treatment of multiple sclerosis. Learn more
BREAKING NEWS: 34 new research projects launched totaling $14.6 million to propel MS research. Grants are part of an annual investment in cutting-edge research projects, moving us closer to a world free of MS. Read more